Gastric Ulcer
📧 Sign up to get email alerts when something new happens for Gastric Ulcer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-08-06FDA Approved: FAMOTIDINE — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved the original ANDA application for famotidine from Novadoz Pharmaceuticals LLC, enabling a generic version of famotidine to reac…
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers [NA]
Clinical trial compares pharmacodynamics and pharmacodynamic equivalence of Antareit 800 mg/10 ml oral suspension and Riopan 800 mg chewable…
-
FDA approval · 2024-07-17FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Somerset Therapeutics, LLC)
FDA approved a supplemental application for esomeprazole magnesium by Somerset Therapeutics, LLC.
-
FDA approval · 2024-07-05FDA Approved: LANSOPRAZOLE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Lansoprazole from Mylan Pharmaceuticals Inc. under an existing ANDA, approving a generic version…
-
CLINICAL_TRIALS trial_result · 2024-06-07Clinical Trial Update: Hypoxia During Gastroenterological Endoscope Procedures Sedated With Ciprofol In Overweight Or Obesity Patients [Phase 4]
Phase 4 clinical trial update examining hypoxia risk during gastroenterological endoscope procedures sedated with Ciprofol in overweight/obe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-05-28FDA Approved: FAMOTIDINE — Original Application (LEADER/ Cardinal Health 110, Inc.)
FDA approved the original ANDA for famotidine from LEADER/ Cardinal Health 110, Inc., providing a generic version of famotidine.
-
FDA approval · 2024-05-21FDA Approved: SUCRALFATE — Original Application (Strides Pharma Science Limited)
The FDA approved Strides Pharma Science Limited's generic sucralfate under an Original Application (ANDA).
-
FDA approval · 2024-05-14FDA Approved: LANSOPRAZOLE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approves a supplemental application for Lansoprazole from Dr. Reddy's Laboratories Inc., authorizing changes to an existing generic prod…
-
FDA approval · 2024-05-03FDA Approved: LANSOPRAZOLE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for lansoprazole from Mylan Pharmaceuticals Inc., indicating an amendment to the approved generic pr…
-
FDA approval · 2024-04-15FDA Approved: PANTOPRAZOLE SODIUM I.V. — Supplemental Application (Piramal Critical Care)
The FDA approved a supplemental application for Pantoprazole Sodium for Injection (IV), submitted by Piramal Critical Care, enabling its con…
-
FDA approval · 2024-04-05FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Edenbridge Pharmaceuticals LLC.)
FDA approved a supplemental application for pantoprazole sodium from Edenbridge Pharmaceuticals LLC., indicating an approved modification un…
-
FDA approval · 2024-03-21FDA Approved: SUCRALFATE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved Ingenus Pharmaceuticals' original application for sucralfate (generic formulation).
-
FDA approval · 2024-02-23FDA Approved: LANSOPRAZOLE — Supplemental Application (Medcore LLC)
The FDA approved a supplemental application for Lansoprazole submitted by Medcore LLC. The snippet does not specify the exact changes covere…
-
FDA approval · 2024-02-14FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Baxter Healthcare Corporation)
FDA approved Baxter's original application for pantoprazole sodium in 0.9% sodium chloride. It is a proton pump inhibitor used to treat acid…
-
FDA approval · 2024-02-14FDA Approved: LANSOPRAZOLE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for lansoprazole filed by Mylan Pharmaceuticals (ANDA 090763).
-
FDA approval · 2024-01-17FDA Approved: SUCRALFATE — Original Application (TruPharma, LLC)
FDA approves the original application for sucralfate oral by TruPharma, LLC.
-
FDA approval · 2024-01-16FDA Approved: FAMOTIDINE — Original Application (DR. REDDY'S LABORATORIES INC)
The FDA approved the original ANDA for famotidine from Dr. Reddy's Laboratories, authorizing a generic version of famotidine. This is a rout…
-
FDA approval · 2024-01-11FDA Approved: OMEPRAZOLE SODIUM BICARBONATE — Supplemental Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s supplemental application for omeprazole sodium bicarbonate (ANDA 207476), confirming its marketing approva…
-
FDA approval · 2023-12-26FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approves a supplemental application for a generic omeprazole and sodium bicarbonate product from Ajanta Pharma USA Inc.
-
FDA approval · 2023-12-22FDA Approved: FAMOTIDINE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved Rising Pharma Holdings, Inc.'s original ANDA for famotidine, allowing the generic version to enter the market. Famotidine is an…
-
FDA approval · 2023-12-14FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)
The FDA approved a supplemental application for Pepcid AC Maximum Strength (famotidine) from Kenvue Brands LLC, under NDA 020325.
-
FDA approval · 2023-12-11FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Granules Pharmaceuticals Inc.)
FDA approved Granules Pharmaceuticals Inc.'s Pantoprazole Sodium as an original-application generic pantoprazole product.
-
FDA approval · 2023-11-20FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Wal-Mart Stores, Inc.)
The FDA approved Wal-Mart Stores, Inc.'s supplemental application for esomeprazole magnesium, a generic proton pump inhibitor.
-
FDA approval · 2023-11-15FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc)
FDA approved a supplemental application for esomeprazole magnesium from Sun Pharmaceutical Industries, Inc. under an ANDA process, indicatin…
-
FDA approval · 2023-11-14FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Camber Pharmaceuticals' generic esomeprazole magnesium. This action confirms regulatory appr…